LSIIF logo

Lisi S.A. (LSIIF) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Lisi S.A. (LSIIF) opera en el sector Industrials, cotizado por última vez a $ con una capitalización de mercado de 0. Calificado con 47/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.

Ultimo analisis: 16 mar 2026
Puntuación de IA de 47/100

Perfil de Operaciones Industriales de Lisi S.A. (LSIIF)

CEOEmmanuel Viellard
Empleados10167
Sede CentralBelfort, FR
Año de la oferta pública inicial (OPI)2013

Lisi S.A., founded in 1777, provides assembly and component solutions for the aerospace, automotive, and medical industries internationally. With a market capitalization of $2.69 billion and a P/E ratio of 16.14, Lisi operates through three divisions, focusing on high-value-added components and assemblies.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 16 mar 2026

Tesis de Inversión

Lisi S.A. presents a compelling investment case based on its diversified exposure to the aerospace, automotive, and medical sectors. The company's focus on high-value-added components and assemblies provides a degree of resilience against economic cycles. With a market capitalization of $2.69 billion and a profit margin of 7.9%, Lisi demonstrates financial stability. Key growth catalysts include the recovery of the aerospace industry, increasing demand for advanced automotive components, and the expanding market for medical implants. Potential risks include fluctuations in raw material prices and competition from other industrial manufacturers. The company's dividend yield is 0.79%.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Market Cap of $2.69B indicates substantial company size and investor confidence.
  • P/E ratio of 16.14 suggests the company is reasonably valued compared to its earnings.
  • Profit Margin of 7.9% reflects the company's ability to generate profit from its revenue.
  • Gross Margin of 31.6% demonstrates efficient cost management in production.
  • Dividend Yield of 0.79% provides a modest return to investors.

Competidores y Pares

Fortalezas

  • Diversified exposure to aerospace, automotive, and medical industries.
  • Established relationships with major customers.
  • Proprietary technology and expertise.
  • Strong financial performance.

Debilidades

  • Exposure to cyclical industries.
  • Reliance on raw material prices.
  • Competition from other industrial manufacturers.
  • OTC market trading can impact liquidity.

Catalizadores

  • Upcoming: Recovery in the aerospace industry leading to increased demand for LISI Aerospace components.
  • Ongoing: Automotive electrification driving demand for LISI Automotive's lightweight fastening solutions.
  • Ongoing: Innovation in medical devices boosting demand for LISI Medical's implants and instruments.
  • Upcoming: Potential strategic acquisitions to expand product portfolio and geographic reach.
  • Ongoing: Operational efficiency improvements to enhance profitability and competitiveness.

Riesgos

  • Potential: Economic downturn impacting demand in the aerospace, automotive, and medical industries.
  • Potential: Fluctuations in raw material prices increasing production costs.
  • Potential: Increased competition from other industrial manufacturers.
  • Ongoing: Regulatory changes affecting the aerospace, automotive, and medical industries.
  • Ongoing: OTC market trading can impact liquidity and increase volatility.

Oportunidades de crecimiento

  • Aerospace Recovery: The resurgence of the aerospace industry, driven by increased air travel and aircraft orders, presents a significant growth opportunity for LISI Aerospace. As airlines expand their fleets and aircraft manufacturers ramp up production, demand for Lisi's aerospace components, including fasteners and structural parts, is expected to increase. This growth is supported by long-term contracts and the company's established relationships with major aerospace players. The timeline for this growth is ongoing, with a projected market size increase of 5-7% annually.
  • Automotive Electrification: The shift towards electric vehicles (EVs) and hybrid electric vehicles (HEVs) is creating new opportunities for LISI Automotive. The company's expertise in developing lightweight and high-strength fastening solutions is well-suited for the EV market, where weight reduction and performance are critical. Lisi can capitalize on the growing demand for EV components by expanding its product portfolio and targeting new customers in the EV supply chain. This growth is anticipated to accelerate over the next 3-5 years, with the EV market projected to grow at a CAGR of 20-30%.
  • Medical Device Innovation: The medical device industry is characterized by continuous innovation and technological advancements. LISI Medical can drive growth by investing in research and development to develop new and improved medical implants and instruments. The company can also expand its presence in emerging markets, where demand for medical devices is growing rapidly. This growth is expected to continue over the next decade, driven by an aging population and increasing healthcare spending. The global medical device market is projected to reach $600 billion by 2030.
  • Strategic Acquisitions: Lisi S.A. can pursue strategic acquisitions to expand its product portfolio, geographic reach, and technological capabilities. Acquisitions can provide access to new markets, customers, and technologies, accelerating the company's growth and strengthening its competitive position. Lisi can target companies in the aerospace, automotive, and medical industries that offer complementary products or services. The timeline for acquisitions is opportunistic, depending on market conditions and available targets. Successful acquisitions can contribute significantly to Lisi's long-term growth.
  • Operational Efficiency Improvements: Lisi S.A. can improve its profitability and competitiveness by implementing operational efficiency improvements across its three divisions. This includes streamlining manufacturing processes, reducing waste, and optimizing supply chain management. By improving its operational efficiency, Lisi can lower its costs, increase its margins, and enhance its customer service. The timeline for operational efficiency improvements is ongoing, with continuous efforts to identify and implement best practices. These improvements can contribute to a 1-2% increase in profit margins over the next 2-3 years.

Oportunidades

  • Aerospace recovery.
  • Automotive electrification.
  • Medical device innovation.
  • Strategic acquisitions.

Amenazas

  • Economic downturn.
  • Fluctuations in raw material prices.
  • Increased competition.
  • Regulatory changes.

Ventajas competitivas

  • High barriers to entry due to stringent quality standards and regulatory requirements.
  • Established relationships with major customers in the aerospace, automotive, and medical industries.
  • Proprietary technology and expertise in designing and manufacturing high-value-added components.
  • Diversified exposure to multiple industries, reducing reliance on any single sector.

Acerca de LSIIF

Lisi S.A., tracing its origins back to 1777, has evolved from GFI Industries into a prominent provider of assembly and component solutions. Headquartered in Belfort, France, Lisi operates globally, serving the aerospace, automotive, and medical industries. The company's structure is organized into three divisions: LISI Aerospace, LISI Automotive, and LISI Medical. LISI Aerospace provides critical components such as titanium nuts, lightning strike protection, and complex engine parts for the LEAP engine and Airbus aircraft. LISI Automotive delivers fastening and assembly solutions for automotive systems, including braking, safety, and interior components. LISI Medical focuses on designing and manufacturing implants and instruments for orthopedic and surgical applications. Lisi S.A. is a subsidiary of Compagnie Industrielle De Delle S.A.

Qué hacen

  • Designs and manufactures assembly and component solutions.
  • Serves the aerospace industry with titanium nuts, lightning strike protection, and engine components.
  • Provides fastening and assembly solutions for the automotive industry.
  • Offers medical implants and instruments for orthopedic and surgical applications.
  • Engages in designing and modeling, prototypes, and pre-series production.
  • Provides solutions for weight reduction and optimizing assemblies in the automotive sector.
  • Offers spinal and trauma implants, such as connectors, screws, cages, and plates for medical use.

Modelo de Negocio

  • Manufacturing and selling high-value-added components and assemblies to aerospace, automotive, and medical industries.
  • Providing customized solutions tailored to specific customer needs.
  • Generating revenue through long-term contracts and recurring orders.
  • Investing in research and development to develop new and innovative products.

Contexto de la Industria

Lisi S.A. operates in the industrial sector, specifically within the aerospace & defense, automotive, and medical industries. These sectors are characterized by high barriers to entry, stringent quality standards, and long-term contracts. The aerospace industry is experiencing a recovery, driven by increased air travel and aircraft production. The automotive industry is undergoing a transformation with the rise of electric vehicles and advanced driver-assistance systems (ADAS). The medical industry is growing due to an aging population and advancements in medical technology. Lisi competes with companies like AUTLF, CHYCY, CMGMF, CMGMY, and IRRHF.

Clientes Clave

  • Aerospace companies: Airbus, Boeing, and other aircraft manufacturers.
  • Automotive companies: Major automotive OEMs and suppliers.
  • Medical device companies: Hospitals, clinics, and surgeons.
Confianza de la IA: 69% Actualizado: 16 mar 2026

Finanzas

Gráfico e información

Precio de la acción de Lisi S.A. (LSIIF): Price data unavailable

Últimas noticias

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para LSIIF.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para LSIIF.

MoonshotScore

47/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de LSIIF en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: Emmanuel Viellard

Unknown

Information about Emmanuel Viellard's background is not available in the provided context. Therefore, details regarding his career history, education, previous roles, and credentials cannot be provided. More information is needed to complete this section.

Historial: Information about Emmanuel Viellard's track record is not available in the provided context. Therefore, details regarding his key achievements, strategic decisions, and company milestones under his leadership cannot be provided. More information is needed to complete this section.

Información del mercado OTC de LSIIF

The OTC Other tier represents the lowest tier of the OTC market, indicating that Lisi S.A. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited reporting requirements, potentially leading to less transparency for investors. Trading on this tier is often associated with higher risks due to the lack of stringent listing requirements and regulatory oversight compared to major exchanges like the NYSE or NASDAQ.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: As an OTC-listed stock, LSIIF may experience lower trading volumes and wider bid-ask spreads compared to stocks listed on major exchanges. This can make it more difficult for investors to buy or sell shares quickly and at desired prices. The limited liquidity may also increase price volatility, making it challenging to execute large trades without significantly impacting the stock price.
Factores de riesgo OTC:
  • Limited liquidity due to lower trading volumes on the OTC market.
  • Less stringent reporting requirements may result in less transparency.
  • Higher price volatility compared to stocks listed on major exchanges.
  • Potential for wider bid-ask spreads, increasing transaction costs.
  • Risk of delisting or suspension from the OTC market.
Lista de verificación de diligencia debida:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the company's management team and their experience.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's growth prospects and potential risks.
  • Monitor news and announcements related to the company.
  • Consult with a financial advisor before investing.
  • Understand the risks associated with OTC trading.
Señales de legitimidad:
  • The company has been in operation since 1777, indicating a long history.
  • Lisi S.A. serves reputable customers in the aerospace, automotive, and medical industries.
  • The company has a market capitalization of $2.69 billion, suggesting a substantial business.
  • Lisi S.A. operates through three distinct divisions, demonstrating diversification.
  • The company is a subsidiary of Compagnie Industrielle De Delle S.A.

Lo Que los Inversores Preguntan Sobre Lisi S.A. (LSIIF)

¿Cuáles son los factores clave para evaluar LSIIF?

Lisi S.A. (LSIIF) actualmente tiene una puntuación IA de 47/100, indicando puntuación baja. Fortaleza clave: Diversified exposure to aerospace, automotive, and medical industries.. Riesgo principal a monitorear: Potential: Economic downturn impacting demand in the aerospace, automotive, and medical industries.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de LSIIF?

LSIIF actualmente puntúa 47/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de LSIIF?

Los precios de LSIIF se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre LSIIF?

La cobertura de analistas para LSIIF incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en LSIIF?

Las categorías de riesgo para LSIIF incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Economic downturn impacting demand in the aerospace, automotive, and medical industries.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de LSIIF?

La relación P/E para LSIIF compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está LSIIF sobrevalorada o infravalorada?

Determinar si Lisi S.A. (LSIIF) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de LSIIF?

Lisi S.A. (LSIIF) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Information is based on available data and may not be comprehensive.
  • AI analysis is pending for LSIIF.
Fuentes de datos

Popular Stocks